Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Erytech Pharma S.A. - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.68

up-down-arrow $-0.02 (-2.63%)

As on 26-Jul-2023 09:30EDT

Market cap

info icon

$47 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 148.10 120.37 95.07 25.04 13.98
Net Profit 215.53 151.57 101.16 26.20 15.05
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -116.54-85.44-0.98-217.87-130.78
Return on Capital info -67.07-54.98-0.53-105.27-95.40
Return on Assets info -49.07-42.40-0.41-73.11-73.69
Debt to Equity (x) info ----0.581.111.03

Profitability

View Detailed Peer Comparison

ROCE

-0.53

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
-0.53
-105.27
-95.40
-50.67
-23.03
Peer Median
--
--
--
--
--
ROE

-0.98

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
-0.98
-217.87
-130.78
-54.21
-23.38
Peer Median
--
--
--
--
--
ROA

-0.41

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
-0.41
-73.11
-73.69
-43.76
-21.05
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
EBIT Growth

95.05

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
95.05
17.89
-7.43
-67.68
-14.01
Peer Median
--
--
--
--
--
Net Profit Growth

99.58

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
99.58
26.61
-16.98
-63.93
-14.00
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.58

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
0.58
1.11
1.03
0.17
0.01
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.14

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
0.14
0.09
0.15
0.02
0.01
Peer Median
--
--
--
--
--
Current Ratio

3.65

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
3.65
2.00
1.69
4.10
7.26
Peer Median
--
--
--
--
--
Quick Ratio

3.54

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
3.54
2.00
1.69
4.09
7.19
Peer Median
--
--
--
--
--
Interest Coverage

-2.05

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
-2.05
-26.43
-12.86
-41.80
-4,245.89
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
1.14
6.14
8.58
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
31.02
76.03
134.95
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Erytech Pharma S.A. - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
loading...
loading...